Spots Global Cancer Trial Database for The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients

Official Title: The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients

Study ID: NCT03224572

Conditions

Vitamin C Deficiency

Interventions

high-dose vitamin C 30gm

normal saline

Study Description

Brief Summary: This study determines whether high dose vitamin C is effective for quality of life in terminal cancer patients.

Detailed Description: The investigator's project is a single medical center, randomized double- blinded trial. The target group is terminal cancer patients at Palliative care clinics. The experimental group will receive intravenous high-dose vitamin C 30 g in 500 ml normal saline in 1-hour infusion, once per week, and total 4-week treatment. The control group will receive 500 ml normal saline in 1-hour infusion, once per week, and total 4-week treatment. The primary outcome is the improvement of quality of life, measured by European Organization for Research and Treatment of cancer (EORTC). The secondary outcome is the survival analysis.The participants will be followed up weekly for 2 weeks, then bi-weekly for 6 months.